Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial

INTRODUCTION: There is some evidence that non-steroidal anti-inflammatory drugs (NSAIDs), in particular celecoxib, might possess not only a symptomatic efficacy but also disease-modifying properties in ankylosing spondylitis (AS), retarding the progression of structural damage in the spine if taken...

Descripción completa

Detalles Bibliográficos
Autores principales: Proft, Fabian, Muche, Burkhard, Listing, Joachim, Rios-Rodriguez, Valeria, Sieper, Joachim, Poddubnyy, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623356/
https://www.ncbi.nlm.nih.gov/pubmed/28601821
http://dx.doi.org/10.1136/bmjopen-2016-014591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623356/
https://www.ncbi.nlm.nih.gov/pubmed/28601821
http://dx.doi.org/10.1136/bmjopen-2016-014591

Ejemplares similares